Effects of probiotic therapy on cardio-metabolic parameters and autonomic modulation in hypertensive women: a randomized, triple-blind, placebo-controlled trial

Background and aims : We assessed the effects of probiotic therapy for 8 weeks on cardiometabolic variables and autonomic function in women medically diagnosed with arterial hypertension. Methods and results : Forty women with arterial hypertension, 20-50 years, were assigned to two groups in this r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food & function 2020-08, Vol.11 (8), p.7152-7163
Hauptverfasser: Romão da Silva, Larissa de Fátima, de Oliveira, Yohanna, de Souza, Evandro Leite, de Luna Freire, Micaelle Oliveira, Braga, Valdir de Andrade, Magnani, Marciane, de Brito Alves, José Luiz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and aims : We assessed the effects of probiotic therapy for 8 weeks on cardiometabolic variables and autonomic function in women medically diagnosed with arterial hypertension. Methods and results : Forty women with arterial hypertension, 20-50 years, were assigned to two groups in this randomized, triple-blind, placebo-controlled clinical trial. Patients in the probiotic group received a daily sachet containing Lactobacillus para casei LPC-37, Lactobacillus rhamnosus HN001, Lactobacillus acidophilus NCFM, and Bifidobacterium lactis HN019 (10 9 CFU of each strain) for 8 weeks. Patients in the placebo group received identical sachets with polydextrose (1 g day −1 , for 8 weeks). Anthropometric, BP, electrocardiogram, biochemical measurements, fecal microbiota composition, and glucose hydrogen breath test were assessed at baseline and after 8 weeks intervention. Anthropometric variables (weight, BMI, and waist circumference) were similar between the two groups ( p > 0.05). Probiotic supplementation significantly reduced fasting glucose (change −10.3 mg dL −1 , p < 0.05) and cholesterol levels (change −23.6 mg dL −1 , p < 0.05), and increased the HDL-cholesterol (change 6.5 mg dL −1 , p < 0.05) compared with the baseline condition. Probiotic supplementation lowered, although without statistical significance, systolic BP by about 5 mmHg and diastolic BP by about 2 mmHg in hypertensive women. Lastly, probiotic administration reduced the low frequency (LF) oscillation and LF/high frequency (HF) ratio ( p < 0.05) in the frequency domain of heart rate variability, suggesting an improvement in autonomic modulation. Conclusion : Probiotic therapy for 8 weeks reduced fasting glucose levels, and improved the lipid profile and autonomic modulation in hypertensive women. We assessed the effects of probiotic therapy for 8 weeks on cardiometabolic variables and autonomic function in women medically diagnosed with arterial hypertension.
ISSN:2042-6496
2042-650X
DOI:10.1039/d0fo01661f